Heterologous T cell immunity in severe hepatitis C virus infection

Journal of Experimental Medicine

Volumn 201, Issue 5, 2005, Pages 675-680

  Urbani, Simona ^a   Amadei, Barbara ^a   Fisicaro, Paola ^a   Pilli, Massimo ^a   Missale, Gabriele ^a   Bertoletti, Antonio ^b,c   Ferrari, Carlo ^a  

^a UNIVERSITY HOSPITAL OF PARMA   (Italy)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; CYSTEINYLISOLEUCYLASPARAGINYLGLYCYLVALYLCYSTEINYLTRYPTOPHYLTHREONYLVALINE; EPITOPE; UNCLASSIFIED DRUG;

ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS REACTION; DISEASE COURSE; DISEASE MODEL; DISEASE SEVERITY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; LIVER DISEASE; MEMORY CELL; PRIORITY JOURNAL; VIRUS INFECTION;

ACUTE DISEASE; CD8-POSITIVE T-LYMPHOCYTES; CROSS REACTIONS; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; INTERFERON TYPE II; KINETICS; MALE;

EID: 15444375498     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20041058     Document Type: Article

References (23)

1. Farci, P., H.J. Alter, A. Shimoda, S. Govindarajan, L.C. Cheung, J.C. Melpolder, R.A. Sacher, J.W. Shih, and R.H. Purcell. 1996. Hepatitis C virus-associated fulminant hepatic failure. N. Engl. J. Med. 335:631-634.
2. SEIEVA Collaborating Group. 2003. Case fatality rate of acute viral hepatitis in Italy: 1995-2000. An update. Dig. Liver Dis. 35:404-408.
3. Welsh, R.M., and L.K. Selin. 2002. No one is naive: the significance of heterologous T-cell immunity. Nat. Rev. Immunol. 2:417-426.
4. Brehm, M.A., A.K. Pinto, K.A. Daniels, J.P. Schneck, R.M. Welsh, and L.K. Selin. 2002. T cell immunodominance and maintenance of memory regulated by unexpectedly cross-reactive pathogens. Nat. Immunol. 3:627-634.
5. Chen, H.D., A.E. Fraire, I. Joris, M.A. Brehm, R.M. Welsh, and L.K. Selin. 2001. Memory CD8+ T cells in heterologous antiviral immunity and immunopathology in the lung. Nat. Immunol. 2:1067-1076.
6. Selin, L.K., and R.M. Welsh. 2004. Plasticity of T cell memory responses to viruses. Immunity. 20:5-16.
7. Rahman, F., T. Heller, Y. Sobao, E. Mizukoshi, M. Nascimbeni, H. Alter, S. Herrine, J. Hoofnagle, T.J. Liang, and B. Rehermann. 2004. Effects of antiviral therapy on the cellular immune response in acute hepatitis C. Hepatology. 40:87-97.
8. Lauer, G.M., E. Barnes, M. Lucas, J. Timm, K. Ouchi, A.Y. Kim, C.L. Day, G.K. Robbins, D.R. Casson, M. Reiser, et al. 2004. High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection. Gastroenterology. 127:924-936.
9. Sugimoto, K., F. Ikeda, J. Stadanlick, F.A. Nunes, H.J. Alter, and K.M. Chang. 2003. Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection. Hepatology. 38:1437-1448.
10. Wedemeyer, H., E. Mizukoshi, A.R. Davis, J.R. Bennink, and B. Rehermann. 2001. Cross-reactivity between hepatitis C virus and Influenza A virus determinant-specific cytotoxic T cells. J. Virol. 75:11392-11400.
11. Koziel, M.J., D. Dudley, N. Afdhal, A. Grakoui, C.M. Rice, Q.L. Choo, M. Houghton, and B.D. Walker. 1995. HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release. J. Clin. Invest. 96:2311-2321.
12. Cerny, A., J.G. McHutchison, C. Pasquinelli, M.E. Brown, M.A. Brothers, B. Grabbscheid, P. Fowler, M. Houghton, and F. Chisari. 1995. Cytotoxic T lymphocyte response to hepatitis C virus derived peptides containing the HLA-A2.1 binding motif. J. Clin. Invest. 95:521-526.
13. Rehermann, B., K.M. Chang, M. McHutchinson, R. Kokka, M. Houghton, and F.V. Chisari. 1996. Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection. J. Clin. Invest. 98:1432-1437.
14. Urbani, S., J. Uggeri, Y. Matsuura, T. Miyamura, A. Penna, C. Boni, and C. Ferrari. 2001. Identification of immunodominant hepatitis C virus (HCV)-specific cytotoxic T cell epitopes by stimulation with endogenously synthesized HCV antigens. Hepatology. 33:1533-1538.
15. Urbani, S., C. Boni, G. Missale, G.F. Elia, C. Cavallo, M. Massari, G. Raimondo, and C. Ferrari. 2002. Virus-specific CD8+ lymphocytes share the same effector-memory phenotype but exhibit functional differences in acute hepatitis B and C. J. Virol. 76:12423-12434.
16. Lechner, F., N.H. Gruener, S. Urbani, J. Uggeri, T. Santantonio, A.R. Kammer, A. Cerny, R. Phillips, C. Ferrari, G.R. Pape, and P. Klenerman. 2000. CD8+ T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained. Eur. J. Immunol. 30:2479-2487.
17. Thimme, R., D. Oldach, K.M. Chang, C. Steiger, S.C. Ray, and F.V. Chisari. 2001. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J. Exp. Med. 194:1395-1406.
18. Chang, K.M., B. Rehermann, J.G. McHutchison, C. Pasquinelli, S. Southwood, A. Sette, and F.V. Chisari. 1997. Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus. J. Clin. Invest. 100:2376-2385.
19. Betts, M.R., J.M. Brenchley, D.A. Price, S.C. De Rosa, D.C. Douek, M. Roederer, and R.A. Koup. 2003. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J. Immunol. Methods, 281:65-78.
20. Shoukry, N.H., A. Grakoui, M. Houghton, D.Y. Chien, J. Ghrayeb, K.A. Reimann, and C.M. Walker. 2003. Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection. J. Exp. Med. 197:1645-1655.
21. Grakoui, A., N.H. Shoukry, D.J. Woollard, J.H. Han, H.L. Hanson, J. Ghrayeb, K.K. Murthy, C.M. Rice, and C.M. Walker. 2003. HCV persistence and immune evasion in the absence of memory T cell help. Science. 302:659-662.
22. Bertoletti, A., and M.K. Maini. 2000. Protection or damage: a dual role for the virus-specific cytotoxic T lymphocyte response in hepatitis B and C infection? Curr. Opin. Immunol. 12:403-408.
23. Boni, C., B. Amadei, S. Urbani, P. Fisicaro, A. Zerbini, C. Mori, G. Missale, R. Bertoni, A. Azzurri, G. Del Prete, and C. Ferrari. 2004. Antiviral CD8-mediated responses in chronic HCV carriers with HBV superinfection. Hepatology. 40:289-299.